Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full speedApplication ...
Silexion Therapeutics (SLXN) announced the initiation of its regulatory application in Israel for its planned Phase 2/3 clinical trial of SIL204 ...
As India prepares for the upcoming union Budget, the PHD Chamber of Commerce and Industry (PHDCCI) has pitched for a decisive policy and investment push to strengthen agriculture, farmers'' welfare, ...
Master the Cordless Drill, Impact Driver, and Bits with our new course! This video showcases the installation of central air ...